420
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Effects of raltegravir combined with tenofovir/emtricitabine on body shape, bone density, and lipids in African-Americans initiating HIV therapy

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eugenia Negredo, Anna Bonjoch & Bonaventura Clotet. (2016) Management of bone mineral density in HIV-infected patients. Expert Opinion on Pharmacotherapy 17:6, pages 845-852.
Read now

Articles from other publishers (6)

Kunchok Dorjee, Manisha Desai, Tsering Choden, Sanjiv M. Baxi, Alan E. Hubbard & Arthur L. Reingold. (2021) Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States. AIDS Research and Therapy 18:1.
Crossref
Jennifer Gorwood, Christine Bourgeois, Valérie Pourcher, Guillaume Pourcher, Frédéric Charlotte, Matthieu Mantecon, Cindy Rose, Romain Morichon, Michael Atlan, Roger Le Grand, Delphine Desjardins, Christine Katlama, Bruno Fève, Olivier Lambotte, Jacqueline Capeau, Véronique Béréziat & Claire Lagathu. (2020) The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes. Clinical Infectious Diseases 71:10, pages e549-e560.
Crossref
Dmitri Sviridov, Nigora Mukhamedova, Alexander A. Makarov, Alexei Adzhubei & Michael Bukrinsky. (2020) Comorbidities of HIV infection. AIDS 34:1, pages 1-13.
Crossref
Obiageli Offor, Netanya Utay, David Reynoso, Anoma Somasunderam, Judith Currier & Jordan Lake. (2018) Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLOS ONE 13:5, pages e0196395.
Crossref
Lemuel R. Non, Gerome V. Escota & William G. Powderly. (2017) HIV and its relationship to insulin resistance and lipid abnormalities. Translational Research 183, pages 41-56.
Crossref
Sahera Dirajlal-Fargo, Carlee Moser, Todd T. Brown, Theodoros Kelesidis, Michael P. Dube, James H. Stein, Judith Currier & Grace A. McComsey. (2016) Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infectious Diseases 3:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.